WHO classification named “glioblastoma“, is the most widespread and most aggressive brain tumor killing many lives. GBM also accounts for around 12% – 15% of all intracranial tumors and around 50% – 60% of astrocytic tumors with a median survival rate of ~12 months; 5-year survival rate of ~4%. Forsyth and the co-authors have published their outstanding research that brings hope for many Brain tumor Patients. The study lead author conveyed that Oncolytic viruses infecting and breaking down cancer cells offer promising possibilities for overcoming resistance to targeted therapies. This research seems to be rising hopes in many lives.
Peter A. Forsyth, M.D., of Moffitt’s Neuro-Oncology Program say that combination of the myxoma virus and the immune suppressant rapamycin can kill glioblastoma multiforme, the most aggressive and deadliest malignant brain tumor. This combination is effective to infect and kill both brain cancer stem cells and differentiated compartments of glioblastoma multiforme.